Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
736
-
Total 13F shares, excl. options
-
68.6M
-
Shares change
-
-1.16M
-
Total reported value, excl. options
-
$17.9B
-
Value change
-
-$188M
-
Put/Call ratio
-
0.35
-
Number of buys
-
368
-
Number of sells
-
-326
-
Price
-
$262.33
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q3 2025
840 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q3 2025.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 736 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.6M shares
of 71.9M outstanding shares and own 95.38% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.7M shares), BlackRock, Inc. (6.46M shares), STATE STREET CORP (3.21M shares), Bank of New York Mellon Corp (2.9M shares), Artisan Partners Limited Partnership (2.77M shares), BROWN ADVISORY INC (2.5M shares), GEODE CAPITAL MANAGEMENT, LLC (1.86M shares), MORGAN STANLEY (1.48M shares), VAN ECK ASSOCIATES CORP (1.42M shares), and APG Asset Management N.V. (1.41M shares).
This table shows the top 736 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.